Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosomal abnormalities in acute leukemias.

A B Glassman1

  • 1Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, USA.

Clinics in Laboratory Medicine
|March 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reticulum cell sarcoma of lymph node with mixed dendritic and fibroblastic features.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2001
Same author

Detection of trisomy 8 in philadelphia chromosome-positive CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques and its relation to c-myc involvement.

Annals of clinical and laboratory science·2001
Same author

A unique, complex variant philadelphia chromosome translocation in a patient with typical chronic myelogenous leukemia.

Archives of pathology & laboratory medicine·2001
Same author

Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma.

American journal of clinical pathology·2000
Same author

Numeric chromosomal abnormalities in small lymphocytic and transformed large cell lymphomas detected by fluorescence in situ hybridization of fine-needle aspiration biopsies.

Cancer·2000
Same author

Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000

Cytogenetic techniques are crucial for diagnosing and monitoring patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Advanced methods like FISH and molecular diagnostics will be increasingly important for these hematologic malignancies.

Area of Science:

  • Clinical Cytogenetics
  • Hematologic Oncology
  • Molecular Diagnostics

Background:

  • Conventional cytogenetic techniques are the established standard for diagnosing and managing patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
  • Specific chromosomal translocations, including t(8;21), t(15;17), and inv(16), are historically linked to AML subtypes M2, M3, and M4eo, respectively.
  • The t(9;22) translocation is a frequent cytogenetic abnormality observed in both childhood ALL and hyperdiploid adult ALL.

Purpose of the Study:

  • To highlight the pivotal role of the clinical cytogenetics laboratory in the diagnosis and patient management of AML and ALL.
  • To review established cytogenetic abnormalities associated with specific leukemia subtypes.
  • To discuss the evolving landscape of diagnostic techniques in hematologic malignancies.

Related Experiment Videos

Main Methods:

  • Review of conventional cytogenetic techniques used in clinical practice.
  • Identification of characteristic chromosomal translocations in AML and ALL.
  • Discussion of emerging diagnostic modalities.

Main Results:

  • Established cytogenetic markers for AML subtypes (M2, M3, M4eo) and ALL (childhood and hyperdiploid adult) were confirmed.
  • The t(9;22) translocation was identified as a common abnormality in specific ALL populations.
  • The importance of cytogenetics in routine diagnosis and follow-up was emphasized.

Conclusions:

  • Clinical cytogenetics remains fundamental for the diagnosis and management of AML and ALL.
  • Future directions point towards the integration of fluorescence in situ hybridization (FISH) and molecular diagnostic techniques.
  • These advanced methods are expected to enhance diagnostic accuracy and patient care in hematologic malignancies.